Academic Staff
|
|
Professor
Angela Clow
Tel: 0207 911 5000 ext: 2174
|
Click here to find articles available
to download in PDF by Prof Angela Clow
Research
Interests
Psychophysiology; Psychoneuroimmunology;
Physiological Psychology; Health Psychology; well-being
General Information
Professor Angela Clow is trained in
neuropharmacology, physiology and psychology and likes to work at
the interface of these disciplines. For her PhD (Institute of
Psychiatry, London) she investigated the function of brain dopamine
receptors and during her post-doctoral studies (Royal Postgraduate
Medical School) she developed an interest in the biochemistry of
stress. In 1989 she joined the University of Westminster where she
became a founder member of the interdisciplinary Psychophysiology
and Stress Research Group (PSRG). Angela’s
current research investigates the physiological pathways by which
stress and well-being can affect health. In particular she studies
daily patterns of cortisol secretion, a hormone important in the
regulation of day-night cycles as well as stress responding.
Professor Clow has published over 95 full-length peer-reviewed
papers, 2 books, and 25 book chapters or reviews. Angela is an
Honorary Vice-President of the International
Stress Management Association and the Society
for Coaching Psychology.
Currently Angela is supervising
2 PhD
students and 1 post-doctoral Research Associate. From
across the University Angela collaborates with Professor Frank
Hucklebridge, and with Dr Alizon
Draper (on the Wellcome-funded evaluation of Well
London.)
Angela is a lead academic in the development
of a new interdisciplinary Institute of Well-being and Health at
the University. This initiative has attracted substantial
University investment and brings together colleagues from across
the University with a shared interest in well-being and
health.
Angela is a National
Teaching Fellow and has been involved in media activities
such as a BBC1 series called The Stress Test,
Woman’s’ Hour and All in the Mind.
Publications:
Jump to Conference Presentations and
Book Chapters.
Books:
Clow A and Hucklebridge F (2002).
(Eds.) International Review of Neurobiology. 52. The
Neurobiology of the Immune System. Academic Press. New
York.
Evans P, Hucklebridge F, and Clow
A. (2000) Mind, Immunity and Health: The Science of
Psychoneuroimmunology. Free Association Books, London, .
Published full length
refereed papers:
Clow,
A., Hucklebridge, F., Stalder, T., Evans,
P. and Thorn, L. (in press). The cortisol awakening
response: more than a measure of HPA axis function. Neuroscience
and Biobehavioral Reviews, special issue: Psychophysiological
Biomarkers of Health
Stalder,T., Evans, P. Hucklebridge, F., Clow, C. (2010).
Associations between psychosocial state variables and the cortisol
awakening response in a single case study.
Psychoneuroendocrinology, 35, 209—214
Wall M, Hayes R, Moore D,
Petticrew M, Clow A, Schmidt E, Draper A, Lock K, Lynch R, Renton
A. (2009). Evaluation of community level interventions to address
social and structural determinants of health: a cluster randomised
controlled trial. BMC Public
Health 2009, 9:207
Stalder T, Hucklebridge F, Evans P,
Clow A. (2009). Use of a Single Case Study Design to Examine State
Variation in the Cortisol Awakening Response: Relationship with
Time of Awakening. Pyschoneuroendocrinology
34, 607-614
Thorn L, Hucklebridge F, Evans P,
Clow A. (2009). The awakening cortisol response: day differences in
relation to state variables and trait seasonality,
Pyschoneuroendocrinology, 34, 299-306
Oskis, A., Loveday, C.,
Hucklebridge, F., Thorn, L., Clow., A. (2009). Diurnal patterns of
salivary cortisol across the adolescent period in healthy females,
Psychoneuroendocrinology,34, 307-316
Ostir, G.V., Berges, I.M.,
Ottenbacher, M.E., Clow, A. & Ottenbacher,
K.J. (2008). Associations between positive
emotion and recovery of functional status following stroke,
Psychosomatic Medicine, 70, 404-409
Evans P, Forte D, Jacobs C, Fredhoi C, Aitchison E ,
Hucklebridge F, Clow A. (2007)Cortisol secretory activity in
older people in relation to positive and negative well-being.
Psychoneuroendocrinology, 32, 922-930
Thorn, L., Hucklebridge, F., Evans, P. and Clow,
A. (2006) Suspected non-adherence and weekend versus week
day differences in the awakening cortisol response. Psychoneuroendocrinology, 31,
1009-1018
Bullen, V., Fredhoi, C., Bloom, W.,
Povey, J., Hucklebridge, F., Evans, P. and Clow, A., (2006)
Salivary cortisol, stress and arousal following five weeks training
in kinesthetic meditation to undergraduate students. Journal of
Holistic Healthcare, 3(3), 34-38
Clow A and Fredhoi C (2006) Normalisation of salivary cortisol
levels and self-report stress by a brief lunchtime visit to an art
gallery by London City workers. Journal of Holistic Healthcare,
3(2), 29-32
Clow A, Edwards S, Owen G, Evans
G, Evans P, Hucklebridge F and Casey A. (2006)
Post-awakening cortisol secretion
during basic military training. International Journal of
Psychophysiology, 60, 88-94
Ussher M, West R, Evans P, Steptoe A, McEwen A, Clow A and
Hucklebridge F. (2006)
Reduction in cortisol after
smoking cessation among users of nicotine patches. Psychosomatic
Medicine, 68, 299-306
Phillips A, Carroll D, Evans P,
Bosch JA, Clow A, Hucklebridge F and Der G. (2006) Stressful life
events are associated with low secretion rates of immunoglobin A in
saliva in the middle aged and elderly. Brain, Behavior and
Immunity, 20, 191-197
Hucklebridge F, Hussain, T,
Evans P, Clow A, (2005) The diurnal pattern of the adrenal steroids
cortisol and dehydroepiandrosterone (DHEA) in relation to
awakening. Psychoneuroendocrinology, 30, 51-57
Clow, A. (2004) Cortisol as a
biomarker of stress. Journal of Holistic Healthcare, 1, 10-14
Ussher M, West R, Evans P,
Steptoe A, McEwen A, Clow A and Hucklebridge F. (2004) Acute
reduction in secretory immunoglobulin A concentration and secretion
rate following smoking session. Psychoneuroendocrinology. 29,
1335-1340
O'Regan, C. & Clow, A.
(2004). Decreased pain tolerance and mood in recreational users of
MDMA. Psychopharmacology, 173, 446-451.
Thorn L, Hucklebridge F, Esgate
A, Evans P, Clow A. (2004). The effect of dawn simulation on the
cortisol response to awakening in healthy participants.
Psychoneuroendocrinology. 29, 925-930.
Persson Waye K, Agge A, Clow A
and Hucklebridge F. (2004) Cortisol response after low-frequency
noise exposure. Journal of Sound and Vibration, 277, 453-457
Clow A, Thorn L, Evans P, Hucklebridge F. (2004). The awakening
cortisol response: methodological issues and significance. Stress,
7, 29-37.
Edwards S, Hucklebridge F, Clow A, Evans P. (2003). Components of
the diurnal cortisol cycle in relation to upper respiratory
symptoms and perceived stress. Psychosomatic medicine. 65,
320-327.
Persson Waye K, Clow A, Edwards
S, Hucklebridge F, Rylander, R. (2003). Effects of nighttime low
frequency noise on the cortisol response to awakening and
subjective sleep quality. Life Sciences, 72, 863-875.
Clow A, Lambert S, Evans P,
Hucklebridge F, Higuchi K. (2003). An investigation into
asymmetrical cortical regulation of salivary S-IgA in conscious man
using transcranial magnetic stimulation. International Journal of
Psychophysiology, 47, 57-64.
Kunikowska G, Gallagher I, Glover
V, Clow A, Jenner P. (2002). Effects of short- and long-term
(-)-deprenyl administration on mRNA for copper, zinc- and
manganese-superoxide dismutase and glutathione peroxidase in rat
brain. Brain Research 953, 1-11.
Hucklebridge F, Mellins J, Evans
P, Clow A.(2002) The awakening cortisol response: No evidence for
an influence of body posture; Life sciences, 71, 639-646.
Brooke-Wavell,, K., Clow, A.,
Ghazi-Noori,S. Evans, P. & Hucklebridge, F. (2002) Ultrasound
measures of bone and the diurnal free cortisol cycle: A positive
association with the awakening cortisol response in healthy
premenopausal women; Calcified Tissue International, 70
(6): 463-468 JUN.
Persson Waye K, Bengtsson J,
Rylander R, Hucklebridge F, Evans P and Clow A. Low frequency noise
enhances cortisol among noise sensitive subjects during work
performance. Life Sciences. 745-758 (2002).
Clow A, Hucklebridge F. The
impact of psychological stress on immune function in the athletic
population. Exercise Immunology Review 7, 5-17 (2001).
Edwards S, Evans P, Hucklebridge
F, Clow A. Association between time of awakening and diurnal
cortisol secretory activity. Psychoneuroendocrinology, 26, 613-622
(2001).
Edwards S, Clow A, Evans P,
Hucklebridge F. Exploration of the awakening cortisol response in
relation to diurnal cortisol secretory activity. Life Sci., 68,
2093-2103 (2001).
Hucklebridge F, Lambert S, Clow
A, Warburton DM, Evans PD, Sherwood N. Modulation of secretory
immunoglobulin A in saliva: response to manipulation of mood.
Biological Psycholology, 53, 25-35 (2001).
Hucklebridge F, Clow A, Rahman H,
Evans P. The cortisol response to normal and nocturnal awakening.
J. Psychophysiology, 14, 24-28 (2000).
Gallagher IM, Jenner P, Glover V,
Clow A. CuZn-superoxide dismutase transgenic mice: no effect on
longevity, locomotor activity and 3H mazindol and 3H-spiperone
binding over 19 months. Neuroscience Letters, 289, 221-223
(2000).
Gallagher I, Clow A, Jenner P,
Glover V. Long term effects of pergolide and (-)-deprenyl on
3H-mazindol and 3H-spiperone binding in rat brain. Neurobiology of
Ageing 20, 709-713 (2000).
Clow A, Vellucci SV, Parrott RF,
Hucklebridge F, Sen S, & Evans P. Endogenous monoamine oxidase
inhibitory activity and HPA activation in the pig. Life Sci., 66,
35-41 (2000).
Gallagher I, Clow A, Jenner P,
Glover V. Effect of long-term administration of pergolide and (-)
-deprenyl on age related decline in Hole Board activity and
antioxidant activity in rats. Biogenic Amines, 15, 379-393
(1999).
Hucklebridge F, Clow A,
Abeyguneratne, Huezo-Diaz P, Evans P. The awakening cortisol
response and blood glucose levels. Life Sci., 64, 931-937
(1999).
Hucklebridge F, Clow A, Evans, P.
The relationship between salivary secretory immunoglobulin A and
cortisol: neuroendocrine response to awakening and the diurnal
cycle. Int. J. Psychophys., 31, 69-76 (1998).
Hucklebridge F, Sen S, Evans P,
Clow A. The relationship between circadian patterns of salivary
cortisol and endogenous inhibitor of monoamine oxidase A. Life
Sci., 62, 2321-2328 (1998).
Willemsen G, Ring C, Evans P,
Clow A, Hucklebridge F, Carroll D. Secretory immunoglobulin A and
cardiovascular responses to mental arithmetic and cold pressor.
Psychophysiology, 35, 252-259 (1998).
Hucklebridge, F, Doyle, A, Pang,
F-Y, Adlard, M, Evans, P, Clow A. Regional and molecular separation
of the four bioactivities of 'tribulin'. Neurosci. Let., 240, 29-32
(1998).
Clow A, Doyle A, Hucklebridge F,
Carroll D, Ring C, Shrimpton J, Willemsen G, Evans P. Endogenous
monoamine oxidase A inhibitory activity (tribulin), measured in
saliva, is related to cardiovascular reactivity in normal
individuals. J. Neural Transmiss., (Suppl) 52, 77-83 (1997).
Bristow M, Hucklebridge F, Clow
A, Evans P. Modulation of secretory immunoglobulin A in saliva in
relation to an acute episode of stress and arousal. J. Psychophys.,
11, 248-255 (1997).
Clow A, Patel S, Najafi M, Evans
P, Hucklebridge F. The cortisol response to psychological challenge
is preceeded by a rise in endogenous inhibitor of monoamine
oxidase. Life Sci., 61, 567-575, (1997).
Stones A, Groome D, Clow A,
Hucklebridge F. Raised blood albumin levels are associated with
trait anxiety. Depression & Anxiety, 4, 151-152, (1997).
Evans P, Doyle A, Hucklebridge F,
Clow A. Positive but not negative life events predict vulnerability
to upper respiratory illness. Brit. J. Health Psychol., 1, 339-348,
(1996).
Medvedev AE, Clow A, Sandler M
and Glover V. Isatin: a link between natriuretic peptides and
monamines? Biochem. Pharmacol., 52, 358-391, (1996).
Doyle A, Hucklebridge F, Evans P,
Clow A. Salivary monoamine oxidase A and B inhibitory activities
correlate with stress. Life Sci., 59, 1357-1362, (1996).
Doyle A, Hucklebridge F, Evans P,
Clow A. Urinary output of endogenous monoamine oxidase inhibitory
activity is related to everyday stress. Life Sci., 58, 1723-1730,
(1996).
Doyle A, Pang F-Y, Bristow M,
Hucklebridge F, Evans P, Clow A. Urinary cortisol and endogenous
monoamine oxidase inhibitor(s), but not isatin, are raised in
anticipation of
stress and/or arousal in normal
individuals. Stress Med., 12, 43-49, (1996).
Pang F-Y, Hucklebridge F, Forster
G, Tan K, Clow A. The relationship between isatin and monoamine
oxidase-B inhibitory activity in urine. Stress Med., 12, 35-42,
(1996).
Pattichis K, Louca LL, Clow A,
Glover V. Effects of pergolide, (-)-deprenyl and thioridazine on
soluble SOD, catalase and glutathione peroxidase in rat striata.
Med. Sci. Res., 23, 733-735, (1995).
Evans P, Bristow M, Hucklebridge
F, Clow A. Stress, Arousal, Cortisol and secretory Immunoglobulin A
in students undergoing assessment. Brit. J. Clin. Psychol., 33,
575-576, (1994).
Hucklebridge F, Smith MD, Clow A,
Evans P, Glover V, Taylor A, Adams D, Lydyard PM. Dysphoria and
immune status in post-partum women. Biolog. Psychol., 37, 199-206,
(1994).
Clow A, Freestone C, Lewis E,
Dexter D, Sandler M, Glover V. The effect of pergolide and MDL
72974 on rat brain CuZn superoxide dismutase. Neurosci. Let., 164,
41-43 (1993).
Glover V, Clow A, Sandler M.
Effects of dopaminergic drugs on superoxide dismutase: mplications
for senescence. J, Neural Transm. (suppl), 40, 37-45 (1993).
Evans P, Bristow M, Hucklebridge
F, Clow A, Walters N. The relationship between secretory immunity,
mood and life events. Brit. J. Clin. Psych., 32, 227-236
(1993).
Acolet D, Modi N.
Giannakoulopoulos X, Bond C, Weg W, Clow A, Glover V. Changes in
plasma cortisol and catecholamine concentrations in response to
massage in preterm infants. Archives of Disease in Childhood, 68,
29-31 (1993).
Clow A, Hussain T, Dexter D,
Glover V, Sandler M. Pergolide can induce superoxide dismutase in
rat striata. J. Neural Transm., 90, 27-31 (1992).
Mededev A, Goodwin B, Clow A,
Halket J, Glover V, Sandler M. Inhibitory potency of some isatin
analogues on human monoamine oxidase A and B. Biochem. Pharmacol.,
44, 590-592. (1992).
Clow A, Hussain T, Glover V,
Sandler M, Dexter D, Walker M. (-)-Deprenyl can induce soluble
superoxide dismutase in rat striata. J. Neural. Transm., 86, 77-80
(1991).
Battacharya SK, Clow A, Prareski
A, Halket J, Glover V, Sandler M. Effect of aromatic amino acids,
pentylenetetrazole and yohimbine on isatin and tribulin activity.
Neurosci. Lett., 132, 44-46 (1991).
Halket J, Watkins PJ,
Przyborowska A, Goodwin BL, Clow A, Glover V, Sandler M. Isatin in
urine and tissue. Detection and determination by gas chromatography
and mass spectrometry. J. Chromatog. Biomed. Appl., 562, 279-287
(1991).
Watkins P, Clow A, Halket J,
Przyborowska A, Sandler M. Isatin, regional distribution in rat
brain and tissues. Nuerocham. Int., 17, 321-323 (1990).
Clow A, Glover V, Oxenking GF,
Sandler M. Stress reduces in vivo inhibition of monoamine oxidase
by phenelzine in rat brain. Neurosci. Lett., 107, 331-334
(1989).
Clow A, Davidson J, Glover V,
Halket JM, Milton AS, Sandler M, Walkins PJ. Isatin and tribulin
concentrations are increased in rabbit brain but not liver
following pentylenetetrazole administration. Neuroscience Lett.,
107, 327-330 (1989).
Sandler M, Clow A, Watkins PJ,
Glover V. Tribulin: an endocoid marker for anxiety in man. Stress
Med., 4, 215-219 (1988).
Glover V, Halket JM, Watkins PJ,
Clow A, Goodwin BL, Sandler M. Isatin: identity with the purified
endogenous monoamine inhibitor tribulin. J. Neurochem., 51, 656-659
(1988).
Davidson J, Glover V, Clow A,
Kudler H, Meador K, Sandler M. Tribulin in post-traumatic stress
disorder. Psychological Med., 18, 833-836 (1988).
Clow A, Glover V, Sandler M,
Tiller J. Increased tribulin output in generalised anxiety
disorder. J. Psychopharmacology, 95, 378-380 (1988).
Clow A, Glover V, Weg MW, Walker
PL, Sheehan DV, Carr DB, Sandler M. Urinary catecholamine
metabolite and tribulin output during lactate-induced panic
attacks. Brit. J. Psychiat., 152, 122-126 (1988).
Clow A, Glover V, Sandler M,
Elwes R, Reynolds EH. Tribulin output in neurological disorders.
Brit. J. Clin. Pharmacol., 24, 403-404 (1987).
Elsworth JD, Dewar D, Glover V,
Goodwin BL, Clow A, Sandler M. Purification and characterisation of
tribulin, an endogenous inibitor of monoamine oxidase and of
benzodiazepine receptor binding. J. Neural Transmiss., 67, 145-156
(1986).
Murugaiah K, Theodorou A, Clow A,
Jenner PJ, Marsden CD. Effects of discontinous drug administration
on the development of dopamine supersensitivity during chronic
trifluoperizine or cis-flupenthixol administration to rats.
Psychopharmacology, 86, 228-232 (1985).
Clow A, Glover V, Sandler M.
Triazolam, an anomalous benzodiazepine receptor ligand: in vitro
characterisation of alprazolam and triazolam binding. J.
Neurochem., 45, 621-625 (1985).
Clow A, Glover V, Armando I,
Sandler M. New endogenous benzodiazepine receptor ligand in human
urine: identity with endogenous monoamine oxidase inhibitor. Life
Sci., 33, 735-741 (1983).
Clow, Stolerman IP, Murray RM,
Sandler M. Ethanol preference in rats: increased consumption after
intra-ventricular administration of teterahydropapaveroline.
Neuropharmacology, 22, 563-565 (1983).
Battacharya SK, Glover V, Sandler
M, Clow A, Topham A, Bernadt M, Murray R. Raised endogenous
monoamine oxidase inhibitor output in post-withdrawal alcoholics.
Effects of L-dopa and ethanol. Biol. Psychiat., 17, 687-694
(1982).
Theodorou A, Murugaiah K, Clow A,
Jenner PJ, Marsden CD. Chronic continuous administration of
neuroleptic drugs alters cerebral dopamine receptors and increases
spontaneous dopaminergic action in the striatum. Nature, 296,
570-571 (1982).
Kolbe H, Clow A, Jenner P,
Marsden CD. Neuroleptic-induced acute dystonic reactions may be due
to enhanced release on to supersensitive post-synaptic receptors.
Neurology (NY), 31, 434-439 (1981).
Theodorou A, Gommeren W, Clow A,
Leysen J, Jenner PJ, Marsden CD. Chronic neuroleptic treatment
specifically alters the number of dopamine receptors in rat brain.
Life Sci., 28, 1621-1629 (1981).
Dyer RG, Murugaiah K, Theodorou
A, Clow A, Jenner PJ, Marsden CD. During one year's neuroleptic
treatment in rats, striatal dopamine receptor blockade disappears
but serum prolactin levels remain elevated. Life Sci., 28, 167-174
(1980).
Clow A, Jenner PJ, Theodorou A,
Marsden CD. Cerebral dopamine function in rats following withdrawal
from one year of continuous neuroleptic administration. Eur. J.
Pharmacol., 63, 145-157 (1980).
Clow A, Jenner PJ, Theodorou A,
Marsden CD. A comparison of striatal and mesolimbic function in the
rat during 6 months trifluoperizine administration.
Psychopharmacology, 69, 227-233 (1980).
Clow A, Jenner PJ, Theodorou A,
Marsden CD. Changes in dopamine turnover and receptor activity
during one year's neuroleptic administration. Eur. J. Pharmacol.,
63, 135-144 (1980).
Jenner PJ, Clow A, Reavill C,
Theodorou A, Marsden CD. Stereoselective acctions of substituted
benzamide drugs on cerebral dopamine mechanisms. J. Pharm.
Pharmacol., 32, 39-44 (1980).
Luscombe G, Clow A, Jenner P,
Marsden CD. Antagonism by propranol of cerebral dopamine receptor
stimulation is not related to SYMBOL 97 \f "Symbol" \s
12-adrenergic blockade. J. Pharm. Pharmac., 31, 355-356
(1979).
Clow A, Jenner PJ, Marsden CD.
Changes in dopamine-mediated behaviour during one year's
neuroleptic administration. Eur. J. Pharmacol., 57, 365-375
(1979).
Clow A, Jenner PJ, Theodorou A,
Marsden CD. Neuroleptic drugs and the dopamine hypothesis. Lancet,
i, 934 (1979).
Clow A, Jenner PJ, Theodorou A,
Marsden CD. Striatal dopamine receptors become supersensitive while
rats are given trifluoperizine for six months. Nature, 278, 59-61
(1979).
Clow A, Jenner PJ, Theodorou A,
Marsden CD. An experimental model of tardive dyskinesia. Life Sci.,
23, 421-424 (1978).
Jenner PJ, Clow A, Reavill C,
Theodorou A, Marsden CD. A behavioural and biochemical comparison
of dopamine receptor blockade produced by haloperidol with that
produced by
substituted benzamide drugs. Life
Sci., 23, 545-550 (1978).
Jenner PJ, Elliott PNC, Clow A,
Reavill CD, Marsden CD. A comparison of in vitro and in vivo
dopamine receptor antagonism produced by substituted benzamide
drugs. J. Pharm. Pharmacol., 30, 46-48 (1978).
Gallagher I, Clow A, Glover V.
Long term administration of (-)-deprenyl increases mortality in
male wistar rats. J. Neural Transmiss., (Suppl) 52, 321-326
(1977).
Conference
Presentations:
Hasslet AL, Clow A, Williams DA and
Clauw DJ. Cortisol Awakening Response and Affective Factors in
Fibromyalgia. American College of Rheumatology Scientific Meeting,
Philadelphia, October 2009.
Clow A. The cortisol awakening response as a biomarker of
psychosocial variables, well-being and health. Promoting
growth and well-being amid diversity. City University of Hong
Kong, Hong Kong, June 2009. Keynote speaker
Clow A. Multidimensional assessment of well-being in the
workplace. Workplace well-being: recognising,
anticipating and managing stress. Withers, London, April
2009. Keynote speaker.
Clow A. Multidimensional assessment of well-being in the
workplace. NHS London; HR for London, April 2009.
Keynote speaker.
Hassett AL, Clow A, Williams DA,
Clauw DJ Cortisol Awakening Response and Affective Variables in
FM. Annual European Congress on Rheumatology. Copenhagen,
June 2009
Ussher M, Aveyard P, West R,
Steptoe A, Clow A, Evans P, Hucklebridge F, Ibison J, Reid F.
(2009). The effect of hydrocortisone on desire to smoke and tobacco
withdrawal symptoms. Society of Research on Nicotine and
Tobacco Conference Annual Conference, Dublin April
Thorn L, Hucklebridge
F, Evans P, Clow A. (2009). The cortisol
awakening response, seasonality, stress and arousal: a study of
trait and state influences. Annual meeting of the American
Psychosomatic Society, Chicago, March
Clow A. The Cortisol
Awakening Response as a biomarker of psychosocial variables,
well-being and health. Royal Holloway College, University of
London. March 2009. Invited
speaker
Clow A. Designing more effective
interventions through deeper understanding of well-being Well
London Wellnet annual meting: Measuring Well-Being. (2009).
London, March Keynote Speaker.
Oskis A, Loveday C, Hucklebridge F, Thorn L,
Clow A. Attachment style and HPA axis dysregulation in
healthy female adolescents. Annual meeting of the American
Psychosomatic Society, Chicago, March 2009.
Clow A. Stress, Health and
Happiness. British Psychological Society Manchester
Lectures. Manchester Town Hall, November 2008.
Keynote Speaker
Clow A. Measuring Well-being. Age In
Action: perspectives on Social Well-being. Age Concern Autumn
Conference, Brighton, October 2008. Keynote
Speaker
Loveday C, Clow A, Conway M. A case study of
the awakening cortisol response in amnesia (2008). British
Psychological Society Psychobiology Section Annual conference,
Windermere, September .
O’Connor J, Evans P, Clow A, Peters D,
Cooze P, Lambley R and Lovitt C.(2008). Assessing poor emotional
well-being as a health risk in the NHS Mid-life LifeCheck. Health
Protection conference, University of Warwick, 15-17 September
O’Connor, J., Peters, D., Elkin,
S., Lee, C., Clow, A. & Evans, P. (2008). Development and
evaluation of a self-management intervention in COPD: project
methodology. Enhancing Self Care – Helping People to Help
Themselves. St Andrews, Scotland, September
Stalder, T., Clow, A.,
Hucklebridge, F. & Evans, P. (2008).
Use of a Single Case
Design to Examine State Variation in the Awakening Cortisol
Response (ACR): Relationship with Time of
Awakening. Poster presentation, 39
th Annual
Conference of the International Society for
Psychoneuroendocrinology, Dresden, Germany, July
Stalder, T., Hucklebridge, F., Evans, P. &
Clow, A. (2008). Associations Between State Variation in the
Awakening Cortisol Response (ACR) and Heart Rate Variability (HRV)
in a Single Case Study. Poster presentation,
39th Annual Conference of the International Society for
Psychoneuroendocrinology, Dresden, Germany, July
Stalder, T., Hucklebridge, F., Evans, P., Clow
A. (2008). Associations Between State Variation in the
Awakening Cortisol Response (ACR) and Psychosocial States in a
Single Case Study. Poster presentation, 39th
Annual Conference of the International Society for
Psychoneuroendocrinology, Dresden, Germany, July
Clow A. (2008).
The Link
between stress and health in the workplace.
International Stress Management Association Annual Conference,
June.
Keynote Speaker
Clow A. (2008). Objective measures
of health and well-being. Better Networks for Better Health:
translating research into patient care. WestFocus Life
Science Network, London, June, Invited Speaker
Thorn, L., Evans, P., Hucklebridge, F. &
Clow, A. (2008). The diurnal pattern of
cortisol secretion in relation to season in healthy participants
and seasonal affective disorder. Bial Symposium:
Behind and Beyond the Brain, Porto, Portugal,
March
Thorn, L., Hucklebridge, F., Evans, P., Clow,
A. (2008). The awakening cortisol response: sample-day
variation and self-reported arousal. Poster presentation, BPS
Annual Conference, Dublin, April
Oskis, A., Clow, A., Hucklebridge, F.,
Loveday,. (2008). The diurnal cortisol profile in female
adolescents: the importance of menarche, BPS Annual
Conference, Dublin, April
Oskis, A., Clow, A., Hucklebridge, F. &
Loveday, (2008). Diurnal patterns of cortisol and DHEA in
female adolescents with anorexia nervosa.
39th Annual Conference of the International Society for
Psychoneuroendocrinology, Dresden, Germany, July
Oskis, A., Clow, A., Hucklebridge, F., Thorn,
L. & Loveday, (2008). The diurnal cortisol profile in
female adolescents: relationships with demographic, psychological
and developmental characteristics. 39th Annual
Conference of the International Society for
Psychoneuroendocrinology, Dresden, Germany, July
Clow, A., Towell, A., Fredhoi, C.,
Hucklebridge, F., Evans, P. (2008). Gender and age-related
differences in the diurnal pattern of salivary cortisol
secretion. American Psychosomatic Society
66th Annual Scientific Meeting, Baltimore,
Maryland, March
Clow A. (2008). The link between
stress and health in the workplace. International Stress
Management Association annual conference, London, June,
Invited Speaker
Clow A. (2008). Stress, Health and
Happiness: the Cortisol Connection. Centre for
Rehabilitation Sciences, Sealy Centre on Aging, United Texas
Medical Branch, USA. May, Invited
Speaker
Clow A. (2008). Stress, Happiness
and Health. Colston Symposium on
Farm Animal Welfare and the Interface with Disease. University of
Bristol, April, Keynote Speaker
Clow A. (2007). Using cortisol in
biophilia research. Quantifying biophilia workshop.
University of Oxford, December, Invited
Speaker
Clow A. (2007). Stress, Health and
Happiness (2007). Department of Psychology, University of
Galway, June, Invited Speaker
Clow A. (2007). Stress,
Health and Happiness (2007). Department of Experimental
Psychology Zangwill Club, University of Cambridge, November,
Invited Speaker
Clow, A. (2007). Stress, Health
and Happiness. Psychological Society of Ireland Division of
Health Psychology Annual Conference, Dublin, May, Keynote
Speaker
Clow A. (2007). Stress, Health
and Happiness. British Psychological Society sponsored London
Lectures, London, December, Keynote Speaker
Loveday, C., Oskis, A., Hucklebridge, F.,
Clow, A. (2007). DHEA and cortisol in adolescent anorexia.
Eating Disorders Research Consortium, Cambridge, November
Oskis, A., Clow, A., Hucklebridge, F. &
Loveday, (2007). Hormonal biomarkers in clinical research:
Cortisol and DHEA in adolescent AN. Eating Disorders
Neuro-Network Meeting, University of Westminster, November
Clow, A., Fredhoi, C., Hucklebridge, F.,
Forte, D., Jacobs, C., Aitchison, E., Evans P. (2007). Gender
differences in the diurnal pattern of cortisol secretion in older
adults. 6th World Congress on Stress, Vienna,
October
Clow A. Opportunities for
professional integration in primary heath care research. 36th
Annual Scientific Meeting of the Society for Academic Primary
Care. London, July 2007. Invited
discussant.
Fredhoi C, Towell T, Maguire M, Clow A. Predictors of
positive and negative well-being in older people.1st
Applied Psychology Conference. Warwick, April 2007.
Thorn L, Evans P, Hucklebridge F, Clow A. The awakening
cortisol response in relation to seasonality. The American
Psychosomatic Society annual conference. Prague, March
2007.
Hucklebridge F, Clow A, Evans P, Sen S. Relationship
between evening cortisol and psychological health. The
American Psychosomatic Society annual conference. Prague,
March 2007.
Clow A, Lynam-Smith A, Evans P, Thorn L, Fredhoi C, Hucklebridge
F. Salivary S-IgA secretion during a brief sympathetically
arousing stimulus. The American Psychosomatic Society annual
conference. Prague, March 2007.
Evans P, Clow A, Hucklebridge F, Fredhoi C, Forte D, Aitchison
E. Post-awakening cortisol as a marker of positive and
negative well-being in active seniors. The American
Psychosomatic Society annual conference. Prague, March
2007.
Clow A. Thinking positive: the protective power of
happiness. Institute for Cultural Research, London,
2006. Keynote Speaker
Clow A. Stress, Health and
Happiness. Well-being Workshop at the London School of
Economics, chaired by Lord Layard, 2006. Invited
speaker
Clow A. Stress, Health and Happiness. Launch of the
South East Branch of the British Psychological Society, 2006.
Keynote Speaker
Clow A, Forte D, Aitcheson E,
Jacobs C, Hucklebridge F, Fredhoi C, Loveday C, Evans
P. The diurnal pattern of cortisol secretion in
relation to well-being, life satisfaction and health of older
people. 3rd European Conference on
Positive Psychology, Brada Portugal, July 2006
Invited symposium participant
Clow A. Stress, Health and
Happiness. Edinburgh International Science
Festival. Edinburgh, April
2006. Keynote Speaker
Evans P, Clow A, Hucklebridge F, Thorn L. Stress, awakening
time, weekend vs. weekday sampling, and adherence issues in the
study of the cortisol awakening response. American Psychosomatic
Society Annual conference, Denver USA, March 2006.
Forte D, Jacobs C, Fredhoi C, Clow A. Well-being in seniors:
the meaning of the measure. British Society of Gerontology, Keele,
July 2005
Evans P, Clow A, Hucklebridge F,
Lai J. A meta-analysis of the awakening cortisol response and its
relationship to time of awakening. American Psychosomatic Society,
Vancouver, March 2005
Clow A, Thorn L, Evans P,
Hucklebridge F. The awakening cortisol response: relationship with
self-esteem, perceived stress and light at dawn. Society for
Neuroscience, San Diego, October 2004.
Clow A, Lynam-Smith A, Fredhoi C,Mandzukic-Kanlic L, Hucklebridge
F, Evans P. Salivary volume and S-IgA responses to a brief
sympathetically arousing stimulus - gender matters. Psychobiology
Section of the British Psychological Society Annual Conference,
Cumbria, September 2004.
Fredhoi C, Lynam-Smith A,
Mandzukic-Kanlic L, Hucklebridge F, Thorn L, Evans P, Clow A.
Psychosocial variables and health in an opportunistic sample of
visitors to the Science Museum in London. Psychobiology Section of
the British Psychological Society Annual Conference, Cumbria,
September 2004.
Clow A, Thorn L, Evans P, Hucklebridge F. Invited lecture. The
awakening cortisol response: issues of sampling compliance and
relationship with self-esteem and perceived stress. Eighth
International Congress of Behavioural Medicine. Mainz, Germany.
August 2004.
Clow A, Lynam-Smith A, Fredhoi C,
Evans F, Hucklebridge F. S-IgA in relation to gender, smoking
status and response to a brief sympathetically arousing stimulus.
Psychoneuroimmunology Research Society (PNIRS) conference, Titesee,
Germany, May, 2004.
Clow A, Evans P, Hucklebridge F.
Invited lecture. Chronic stress and the diurnal profile of free
cortisol concentration. British Psychological Society, Division of
Health Psychology Annual Conference. Staffordshire University,
September 2003.
Persson Waye K, Agge A, Clow A,
Hucklebridge F. Sleep disturbance after low frequency noise. In.
The 5Th Japanese-Swedish Noise Symposium on Medical Effects, May
2003, Kirishima Japan.
Hucklebridge F, Thorn L, Esgate A, Evans P, Clow A. The effect of
dawn simulation on the cortisol response to awakening in healthy
participants. Psychoneuroimmunology Research Society (PNIRS)
conference, Florida, USA, June 2003.
Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol
response in relation to perceived stress and symptom reporting.
Psychoneuroimmunology Research Society (PNIRS) conference, Florida,
USA, June 2003.
Thorn L, Clow A, Hucklebridge F, Evans P. The awakening cortisol
response: issues of sampling compliance in a domestic setting.
Psychoneuroimmunology Research Society (PNIRS) conference, Florida,
USA, June 2003.
Persson Waye K, Agge A, Clow A, Hucklebridge F. Cortisol response
and subjective sleep disturbance after low frequency noise. 8th
International Congress on Noise as a Public health problem (ICEBN),
Rotterdam, Holland, January 2003.
Clow A. Invited lecture. The diurnal pattern of cortisol secretory
activity in relation to health and ageing. Brain Immune Network
Group (BING) Bristol 30th November 2002.
Sen S, Clow A, Evans P,
Hucklebridge F. The relationship between salivary cortisol
secretory activity. MAO-A inhibitory activity and their association
with age, mood and health. The 5th International Congress of
Neuroendocrinology. Bristol, September 2002.
Thorn L, Hucklebridge F, Esgate
A, Evans P, Clow A. The effect of dawn simulation on the cortisol
response to awakening in healthy participants. The 5th
International Congress of Neuroendocrinology. Bristol, September
2002.
Hucklebridge F, Sen S, Evans P,
Clow A. Association between stress, cortisol secretory activity,
age and health. Neuroendocrine-Immune Interactions. San-Feliu de
Guixols, Spain, 5-10 October 2002.
Lambert S, Evans P, Hucklebridge
F, Clow A. Secretion of S-IgA and corisol in human subjects can be
modulated by stimulating the cerebral cortex using transcranial
magnetic stimulation; Psychoneuroimmunology Research Society
Meeting, Madison, USA, May 2002.
Edwards S, Clow A, Evans P,
Hucklebridge F. Relationship between diurnal pattern of Salivary
S-IgA and cortisol: Association with psychosocial varibales &
health.Psychoneuroimmunology Research Society Meeting, Madison,
USA, May 2002.
Lambert S, Evans P, Hucklebridge
F, Clow A. TMS to the left and right cerebral cortex differentially
affects S-IgA secretion; BPS Annual conference; Blackpool, 13-16
March 2002.
Clow, A. Salivary sIgA: a
relevant marker of immune function in psychobiological research?
Psychobiology section of BPS conference, Lake district, Sept
2001.
Hucklebridge F, Edwards S, Sear
M, Evans P, Meelins J, Clow A: The awakening cortisol response is
unrelated to postural shift: evidence for an immunoregulatory role.
BPS division of Health Psychology, St Andrews, Sept 2001.
Sen, S; Hucklebridge, F; Evans P,
Clow A. Monoamine oxidase-A inhibitory activity in state and trait
models of psychological stress; British Psychophysiology Society,
Aston, Sept 2001.
Evans P, Clow A, Der G, Ford G,
Hannah MK, Hucklebridge F, Hunt K. Secretory IgA as a biological
marker for stress and health in large-scale survey research.
Psychoneuroimmunology Research
Society Meeting, Utrecht, Netherlands, May 2001.
Hucklebridge F, Edwards S, Evans
P, Clow A. The diurnal pattern of salivary sIgA and stability of
measurement across days. Psychoneuroimmunology Research Society
Meeting, Utrecht, Netherlands, May 2001.
Hucklebridge F, Hussain T, Sen S,
Evans P. The diurnal pattern, in relation to awakening of the
adrenal immunomodulatory steroids cortisol and
dehydoepiandrosterone.
Psychoneuroimmunology Research
Society Meeting, Utrecht, Netherlands, May 2001.
Clow A, Page C, Hucklebridge F,
Evans P. Acute mobilisation of salivary sIgA in association with
transient increases in arousal rather than stress.
Psychoneuroimmunology Research Society Meeting, Utrecht,
Netherlands, May 2001.
Clow A, Mellerio J, Marshall J,
Stephenson C, Doyle A, Evans P, Hucklebridge F. he cortisol
response to photorefractive keratectomy (PRK) ands rate of recovery
from corneal healing. 3rd World Congress on Stress, Dublin,
September 2000.
Clow A, Edwards S, Casey A, Owen
G, Evans G, Evans P, Hucklebridge F. Between-subject differences in
the cortisol awakening response: association with coping style,
fatigue and arousal. 3rd World Congress on Stress, Dublin,
September 2000.
Hucklebridge F, Evans P, Sen S,
Clow A. Endogenous inhibitor of monoamine oxidase A: association
with activity in the hypothalamic-pituitary-adrenal axis. British
Psychophysiology Society Annual Meeting, London, September
2000.
Sen S, Clow A, Thomas A, Evans P,
Hucklebridge F. Serum cortisol and monoamine oxidase a inhibitory
activity in abstinent alcoholics and matched control subjects.
British
Psychophysiology Society Annual
Meeting, London, September 2000.
Clow A, Edwards S, Casey A, Owen
G, Evans P, Evans G, Hucklebridge F. Changes in the cortisol
awakening response: an 11-week longitudinal study. Invited Talk.
British
Psychophysiology Society Annual
Meeting, London, September 2000.
BrookeWavell K, Clow A, Evans P,
Ghazi-Noori S, Hucklebridge F. Relationship between awakening
salivary cortisol and bone quality in premenopausal women. World
Congress on Osteoporosis. Chicago, USA, June, 2000.
Persson Waye K, Rylander R,
Bengtsson J, Clow A, Hucklebridge F, Evans P. Does low frequency
noise induce stress? 9th International meeting: Low frequency noise
and vibration. Aalborg, Denmark, May, 2000.
Hucklebridge F, Edwards S, Clow
A, Tifo D, Evans P. The cortisol response to awakening in relation
to the immune Th1/Th2 balance. Federation of European
Psychophysiology
Societies, Amsterdam, May
2000.
Edwards S, Hucklebridge F, Evans
P, Clow A. The cortisol response to awakening predicts
self-reported cold symptoms. British Psychological Society
Conference, Winchester, February 2000.
Brooke-Wavell K, Clow A, Evans P,
Ghazi-Noori S, Hucklebridge F. Relationship between awakening
salivary cortisol and ultrasound measures of bone in premenopausal
women. 7th Bath Conference on Osteoporosis, Bath, April,
2000.
Clow A, Edwards S, Hucklebridge
F, Rothwell J, Evans P,. Early wakers have higher levels of
cortisol throughout the day. 29th Annual meeting for Neuroscience,
Miami, USA, October 1999.
Edwards S, Hucklebridge F, Evans
P, Clow A. Post-awakening sIgA levels predict activity in the
secretory immune system over the remainder of the day: implications
for psychoneuroimunology research. British Psychophysiology Society
Annual Meeting, London, December 1999.
Edwards S, Hucklebridge F, Evans
P, Clow A. Stability of individual diurnal patterns o salivary sIgA
secretion in healthy subjects. British Psychophysiology Society
Annual Meeting, London, December 1999.
Edwards S, Hucklebridge F, Clow
A, Evans P. Analysis of components of the diurnal pattern of
salivary cortisol in relation to mood. Brain Immune Network Group
Annual Meeting, Bristol, November 1999.
Hucklebridge F, Burns S, Bunt L,
Clow A, Evans P, Jessopp DS, Harbuz M. The influence of music
therapy in cancer patients upon salivary sIgA and cortisol. Brain
Immune Network Group Annual Meeting, Bristol, November 1999.
Clow A, Hucklebridge F, Evans P,
Harbuz M, Jessopp D. Relationship between salivary sIgA and
salivary substance P. Brain Immune Network Group Annual Meeting,
Bristol, November 1999.
Edwards S, Hucklebridge F, Clow
A, Evans P. The cortisol response to awakening in relation to the
diurnal cortisol cycle. British Neuroendocrine Group Annual
Meeting, London, July 1999.
Evans P, Clow A, Derv G,
Hucklebridge F. The relationship between the secretion rate of
secretory immunoglobulin A in saliva (sIgA) and salivary flow as a
function of age, gender, social class and smoking ststus. 5th
European symposium on the application of saliva in
clinical practice and research.
The Netherlands. (May, 1999).
Evans P, Clow A, Hucklebridge F.
In acute paradigms, what makes secretory sIgA in saliva (sIgA) go
up and what makes it go down? 5th European symposium on the
application of saliva in clinical practice and research. The
Netherlands. (May, 1999).
Hucklebridge F, Clow A, Rahman H
& Evans P. The cortisol response to awakening in relation to
the circadian cortisol cycle. British Psychophysiology Society
meeting, London. (December 1998).
Brooke-Wavell K, Clow A, Evans P
& Hucklebridge F. Relationship between the cortisol response to
awakening and bone quality in healthy premenopausal women. British
Psychophysiology Society meeting, London. (December 1998).
Hucklebridge F, Evans P, Clow A,
Zvonar K & Floegel, Awakening cortisol ans salivary sIgA
responses in post traumatic
stress disorder patients. British Psychophysiology Society meeting,
London. (December 1998).
Clow A, Lambert S, Hucklebridge F
& Evans P. The effect of neutral, pleasant and unpleasant
odours on salivary sIgA secretion. British Psychophysiology Society
meeting, London. (December 1998).
Hucklebridge F, Rahman H, Evans
P, Clow A. Invited lecture. The cortisol response to awakening in
relaton to circadian hypothalamic-pituitary-adrenal cycle. Second
World Congress on Stress, Melbourne. (October 1998).
Clow A, Pang F-Y, Evans P,
Mobasheri A & Hucklebridge F. Invited lecture. Isatin in urine
and brain. Invited lecture at the Second World Congress on Styress,
Melbourne. (October 1998).
Clow A, Hucklebridge F, Evans P.
Invited lecture. Cortisol and regulation of monoamine oxidase A
activity. Second World Congress on Stress, Melbourne. (October
1998).
Clow A, Vellucci SV, Parrott RF,
Hucklebridge F, Sen S, Evans P. Endogenous monoamine
oxidase A inhibitory activity and
HPA activation. British Association of Psychopharmacology. (July
1998).
Hucklebridge F, Clow A,
Abeyguneratne T, Huezo-Diaz P, Evans P. The awakening cortisol
response is unrelated to blood glucose. British Association of
Psychopharmacology. (July 1998).
Hucklebridge F, Clow A and Evans
P. Relationships between hypothalamic-pituitary-adrenal activation
and secretory immunoglpbulin A. Research Perspectives in
Psychoneuroimmunology VIII, University of Bristol. (April
1998).
Hucklebridge F, Sweeney P,
Abeyguneratne T, Evans PD, Clow, A. 'The stress of awakening':
Patterns of free salivary cortisol response and salivary sIgA. BING
(Brain Immune Network Group) London. (September, 1997).
Clow A, Lambert S, Hucklebridge
F, Evans PD, Higuchi K, Rothwell JC. Direct evidence for cortical
regulation of immune and glucocorticoid function in healthy
conscious humans. BING (Brain Immune Network Group) London.
(September, 1997)
Hucklebridge F, Abeygunarante T,
Sen S, Evans P and Clow A. Awakening cortisol elevation is
associarted with endogenous MAO-A inhibitory activity. British
Association of Psychopharmacology. Cambridge, England. (July
1997).
Clow A, Lambert S, Hucklebridge
F, Evans P, Higuchi K, Rothwell JC. Asymmetrical cortical
regulation of salivary volume, sIgA and cortisol cortisol
concentration. Invited lecture: 4th laterality and psychopathology
conference, London, England. (June 1997).
Evans P, Clow A and Hucklebridge
F. Stress versus challenge: differential effects on immune system
measures. Invited lecture: Stress of life: stress adaptation from
molecules to man. Budapest, Hungary. (July 1997).
Clow A, Lambert S, Hucklebridge
F, Evans P, Higuchi K, Rothwell JC. Asymmetrical cortical
regulation of salivary volume, sIgA and cortisol cortisol
concentration. Invited lecture: Stress of life: stress adaptation
from molecules to man. Budapest, Hungary. (July 1997).
Hucklebridge F, Evans P and Clow
A. The relation between endogenous inhibitor of monoamine oxidase
and stress in human subjects. Invited lecture: Stress of life:
stress adaptation from molecules to man. Budapest, Hungary. (July
1997).
Evans P, Hucklebridge F, Clow A.
Endogenous monoamine oxidase inhibitory activity as a marker of
psychological stress. Invited lecture: 3rd European Congress of
Psychophysiology, Konstanz, Germany. (May 1997).
Lambert S, Higuchi K,
Hucklebridge F, Rothwell J, Clow, A. Asymmetrical cortical
regulation of immune function. Brain Immune Network Group (BING),
London. (November 1996).
Evans P, Hucklebridge F, Clow A.
Acute psychological challenge induces short-term rises in levels of
secretory immunoglobulin A in saliva. Brain Immune Network Group
(BING), London. (November 1996).
Lambert S, Higuchi K,
Hucklebridge F, Rothwell J, Clow A. Modulation of salivary volume
and salivary secretory immunoglobulin A (sIgA) production in man by
left or right transcranial magnetic stimulation (TMS) of the
tempero-parieto-occipital cortex. British
Psychophysiology Society
Conference, Warwick. (September 1996).
Hucklebridge F, Bristow M, Clow
A, Evans P. Salivary sIgA as an indicator of immune status in
psychophysiology research. British Psychophysiology Society
Conference, Warwick. (September 1996).
Clow A, Doyle A, Hucklebridge F,
Evans P. The relationship between psychological stress and
endogenous monoamnine oxidase (MAO) inhibitory activity measured in
saliva. British Psychophysiology Society Conference, Warwick.
(September 1996).
Stones A, Groome D, Clow.
Relationship between blood albumin levels, stress and Eysenck's
personality inventory (EPI) scores. XXVI International Congress of
Psychology, Canada. ( August 1996).
Doyle A, Adlard M, Hucklebridge
F, Evans P, Clow A. The plasticiser DEHP binds to the peripheral
benzodiazepine receptor. British Association for Psychopharmacology
and Interdisciplinary Society for Biological Psychiatry, Cambridge.
(July 1996).
Gallagher IM, Clow A, Jenner P
and Glover V. The effects of pergolide, (-)-Deprenyl and
Diethyldithiocarbamate on antioxidant enzyme activity and behaviour
in male Wistar rats. The 7th International Amine Oxidase Workshop,
Israel. (June 1996).
Doyle A, Evans P, Hucklebridge F,
Carroll D, Ring C, Shrimpton J, Willemsen G, Clow A. Endogenous
monoamine oxidase A inhibitory activity (tribulin), measured in
saliva, is related to heart rate in normal individuals. The 7th
International Amine Oxidase Workshop, Israel. (June 1996).
Hucklebridge FH, Pang F-Y, Doyle
A, Clow A. The four faces of tribulin - stress related endocoid.
40th OHOLO Conference, Israel. (March 1996).
Evans P, Hucklebridge F, Clow A,
Doyle A. Acute psychological challenge and short-term changes in
levels of secretory immunoglobulin A in saliva. 40th OHOLO
Conference, Israel. (March 1996).
Clow A, Doyle A, Evans P,
Hucklebridge F. Tribulin is related to stress in normal
individuals. 40th OHOLO Conference, Israel. (March 1996).
Clow A, Higuchi K, Lambert S,
Hucklebridge F and Rothwell J. Salivary sIgA production can be
differentially modulated by left and right transcranial magnetic
stimulation (TMS) of the temporal-parietao-ocipital (T-P-O) cortex
in man. Physiology Society, London, (December 1995).
Bristow M, Evans P, Hucklebridge
F and Clow A. Secretory immunoglobulin A (sIgA) predicts upper
respiratory tract infections-but is this an artefact? British
psychological Society (special group in health psychology)
University of the West of England. (September 1995).
Pang F-Y, Trickey R, Hucklebridge
FH, Clow A. The detection of isatin-like immunoreactivity in rat
brain slices. British Association for Psychopharmacology and
Interdisciplinary Society for Biological Psychiatry, Cambridge.
(July 1995)
Pang F-Y, Doyle A, Hucklebridge
F, Evans P, Clow A. Circadian variation in urinary output of the
MAO inhibitory activities of tribulin. British Association for
Psychopharmacology and Interdisciplinary Society for Biological
Psychiatry, Cambridge. (July 1995).
Doyle A, Hucklebridge F, Evans P,
Clow A. Relationship between urinary tribulin output and daily
stressors. British Association for Psychopharmacology and
Interdisciplinary Society for Biological Psychiatry, Cambridge.
(July 1995).
Doyle A, Pang F-Y, Hucklebridge
F, Evans P. Clow, A. Relationship between tribulin and
psychological variables in normal individuals. 6th Symposium on
Catecholamines and other Neurotransmitters in Stress, Smolenice
Castle, Slovakia. (June 1995).
Stones A, Groome D, Clow A.
Relationship between blood albumin levels, stress and EPI scores.
British Psychological Society. London. (December 1994).
Pang F-Y, Clow A, Evans P,
Hucklebridge F. The relationship between urinary monoamine oxidase
B inhibitory activity and isatin. First World Congress on Stress.
National Institute of Mental Health, Maryland, USA. (October
1994).
Evans P, Hucklebridge F, Clow A,
Doyle A. Life events, salivary IgA and the common cold. First World
Congress on Stress. National Institute of Mental Health, Maryland,
USA. (October 1994)
Clow A, Doyle A, Pang F-Y,
Hucklebridge F, Evans P. Monoamines and arousal. First World
Congress on Stress. National Institute of Mental Health, Maryland,
USA. (October 1994).
Pang F-Y, Clow A, Evans P,
Hucklebridge F. Monoamine oxidase B inhibitory activity in urine
cannot be attributed to isatin alone. British Association P &
Interdisciplinary Society for Biological Psychiatry, Cambridge.
(July 1994).
Evans P, Hucklebridge F, Clow A,
Doyle A. Secretory IgA as a convient biomarker in health survey
work. 8th European Health Psychology conference, University of
Alicante, Spain. (July 1994).
Doyle A, Pang F-Y, Bristow M,
Clow A, Hucklebridge F, Evans P. Tribulin and arousal. British
Association P & Interdisciplinary Society for Biological
Psychiatry, Cambridge. (July 1994).
Bristow M, Evans P, Hucklebridge
F, Clow A. Can stress boost your secretory immune system? 8th
European Health Pstchology Conference, University of Alicante,
Spain. (July 1994).
Hucklebridge F, Bristow M, Pang
F-Y, Clow A, Evans P. Stress arousal salivary cortisol and salivary
IgA. 32nd International Congress of Physiological Sciences,
(1993).
Clow A, Dexter D, Sandler M,
Glover V. Rat striatal SOD can be altered by pergolide and
thioridazine but not by MDL 72974. Ist International meeting Old
and New Dopamine agonists in Parkinsons Disease. Pisa, Italy.
(December 1993).
Barrett J, Hucklebridge F, Clow
A, Evens P. Stress and salivary IgA in post traumatic stress
disorder. Health Psychology conference, (September 1993).
Clow A, Kimber J, Sandler M,
Halsrtom C, Hawley C, Glover V. ECT causes an increase in the
urinary output of the MAO A inhibitory component of tribulin.
Summer meeting of the British Psychological Society, (1993).
Clow A, Freestone C, Dexter D,
Sandler M, Glover V. Rat striatal CuZn SOD can be altered by
pergolode and thioridazine but not by MDL 72974. Summer meeting of
the British Psychopharmacology Society (1993).
Glover V, Clow A, Sandler M.
Superoxide dismutase and neuroprotection. 14th ISN Biennial
Meeting, Montpellier, (August 1993).
Pattichis K, Jarman J, Clow A,
Glover V, Sandler M. the effect of red wine on 5-HT levels in human
blood. J Psychopharmac. Abstract Book, A16 (1992).
Clow A, Hussain T, Glover V,
Sandler M. Three weeks administration of (-)-deprenyl can induce
soluble superoxide dismutase in rat striata. J Psychopharm., 6, 103
(1992).
Glover V, Przyborowska A, Clow A,
Watkins P, Bhattacharya SK, Sandler M. Isatin: a new agent in
anxiety? 17th CINP Meeting, Kyoto, (1990). Battacharya SK, Clow A,
Glover V,
Sandler M. Behavioural effects of
isatin, an anxiogenic endocoid. J. Psychopharmacol. 4, 281
(1990).
Clow A, Davidson J, Glover V,
Halket JM, Milton AS, Sandler M, Watkins, PJ. Pentylenetetrazol
increases isatin concentration in rabbit brain but not in liver.
Brit. J. Pharmacol., (1989).
Clow A, Watkins PJ, Glover V,
Halket J, Sandler M. Isatin, a new endocoid in anxiety: regional
distribution in rat. J. Psychpharmacol., 3, 17P (1989).
Glover V, Clow A, Oxenkrug GF,
Sandler M. Effect of stress on the inhibition of rat brain
monoamine oxidase (MAO) A and B by phenelzine. Pharmac. Res.
Commun., 20 suppl 4, 139-140 (1988).
Glover V, Clow A, Oxenkrug GF,
Sandler M. Sress can reduce the effect of an irreversible MAO
inhibitor in vivo. Brit. J. Pharmacol., 94, 320 (1988).
Battacharya S K, Clow A, Glover
V, Sandler M. Anxiogenic agents increase tribulin concentrations in
rat brain and heart. Brit. J. Pharmacol., 93, 1 (1988).
Glover V, Clow A, Sandler M.
Characteristics of tribulin output in man. Pharmac. Toxicol., 60
suppl 1, 19 (1987).
Clow A, Glover V, Sandler M.
Triazolam displacement of 3H-Ro15-1788 and 3H-ethyl-
carboline-3-carboxylate in differenet regions of rat brain. Brit.
J. Pharmacol., 90, 122 (1987).
Glover V, Segarajasinghe CE, Clow
A, Elsworth JD, Sandler M. Endogenous monoamine oxidase inhibitors
in rat brain and human plasma. J. Pharm. Pharmac., 36, 12W
(1984).
Elsworth JD, Clow A, Glover V,
Sandler M. Characterisation of an endogenous inhibitor of monoamine
oxidase and benzodiazepine receptor binding. J. Pharm. Pharmac.,
36, 59W (1984).
Clow A, Glover V, Elsworth JD,
Tiller JWG, Sandler M. Increased tribulin output in general
anxiety disorder. J. Pharm.
Pharmac., 36, 61W (1984).
Glover V, Clow A, Elsworth JD,
Sandler M. Tribulin in anxiety and panic. Clin. Neuropharmacology,
1 suppl 1, 178-179 (1984).
Sandler M, Glover V, Elsworth JD,
Clow A. Ethanol and endogenous ligands in humans. Psychopharmmac.
Bull., 20, 485-486 (1984).
Sandler M, Glover V, Elsworth JD,
Clow A. Tribulin output in anxiety and panic. 137th Ann. Meeting
Am. Psychiat. Ass., Los Angeles, 81-82 (1984)
Clow A, Glover V, Elsworth JD,
Sandler M. Endogenous monoamine oxidase inhibitor and
benzodiazepine receptor ligand in urine. 5th Catecholamine
Symposium, Goteborg, (1983).
Elsworth JD, Clow A, Glover V,
Sandler M. On the identity of "tribulin". 5th Catecholamine
Symposium, Goteborg., 125 (1983).
Clow A, Murray RM, Sandler M,
Stolerman IP. Intraventricular tetrahydropapaveroline increases
alcohol consumption in rats. Brit J. Pharmacol., 75, 54
(1982).
Clow A, Jenner PJ, Marsden CD,
Murugaiah K, Theodorou A. Drug holidays do not prevent the
development of cerebral dopamine receptor supersensitivity during
chronic neuroleptic
administration. Brit. J.
Pharmacol., 73, 242 (1981).
Gommeren W, Leysen J, Clow A,
Jenner PJ, Marsden CD, Theodorou A. Continuous administration of
trifluoperazine to rats for six months only alters cerebral
dopamine receptor characteristics. Brit. J. Pharmacol., 72, 569
(1981).
Jenner PJ, Clow A, Theodorou A,
Marsden CD. Changes in the characteristics of specific 3H-spiperone
binding to striatal preparations from rats treated continuously
with trifluoperazine for up to one year. Neurosci. Lett., suppl 5
(1980).
Clow A, Jenner PJ, Marsden CD,
Theodorou A. Striatal dopamine receptor activity during 6 month's
withdrawal following one year's neuroleptic administration to rats.
Brit. J. Pharmacol., 69, 277 (1980).
Clow A, Jenner PJ, Marsden CD,
Theodorou A. Regional changes in brain dopamine receptor function
during six months trifluoperazine administration to rats. Brit. J.
Pharmacol., 68, 163 (1980).
Clow A, Jenner PJ, Marsden CD,
Reavill C, Theodorou A. Stereoselective blockade of cerebral
dopamine receptors by sulpiride and sultopride. Brit. J.
Pharmacol., 67, 433 (1979).
Clow A, Jenner PJ, Marsden CD,
Pratt J, Reavill C, Thanki C, Theodorou A. Central properties of
-allophanyl- -allyl- valerolactone (valofan). Brit. J. Pharmacol.,
66, 478-479 (1979).
Clow A, Jenner PJ, Marsden CD.
Supersensitivity of cerebral dopamine receptors during on-going
chronic administration of trifluoperazine to rats. Brit. J.
Pharmacol., 64, 414 (1978).
Clow A, Elliott PNC, Jenner PJ,
Marsden CD, Pycock C. Interactions of substituted benzamide drugs
with cerebral dopamine pathways. Brit. J. Pharmacol., 60, 268
(1977).
Book
Chapters:
Clow, A. & Aitchison K.
(in press). Keeping Active: In Mimo, M. & Forte, D.
(Eds.), Mental health and well-being in older
people, Open University Press
Clow A. (2002). Cytokines and
Depression. In. F. Hucklebridge & A. Clow (Eds.),
International Review of Neurobiology. 52. The Neurobiology of
the Immune System. (pp. 255-273.). Academic Press. New
York.
Hucklebridge F & Clow A.
(2002). Neuroimmune Relationships in Perspecive. In. F.
Hucklebridge & A. Clow (Eds.), International Review of
Neurobiology. 52. The Neurobiology of the Immune System. (pp.
1-15.). Academic Press. New York.
Clow A. Behavioural conditioning
of the immune system. IN: Understanding the placebo effect in
complementary medicine: theory, practice and research. Ed: D.
Peters. Churchill Livingstone, London (2001).
Clow A. The physiology of stress.
In: Stress: myth, theory and research. Ds: F. Jones and J. Bright.
Pearson Education Ltd. Harlow (2001)
Gruzelier J, Clow A., Evans P,
Lazar I & Walker L Mind-body influences on immunity:
lateralised control, stress, individual differences, and
prophylaxis. In: Stress of Life: from molecules to man. Ed: P.
Csermely, Annals New York Academy of Sciences, 851, 487-494
(1998).
Clow A, Hucklebridge, F and Evans
P. The role and regulation of monoamines in stress. In: New
Frontiers in Stress Research, Modulation of Brain Function, Eds: De
Kloet, Ben
Nathan, Grauer and Levy. Harwood
Academic Publishere, 21-31 (1998).
Evans P, Clow A, Hucklebridge F.
Stress and the immune system: current issues and directions in
research. The Psychologist, 10, 303-307, (1997).
Doyle A, Pang F-Y, Hucklebridge
F, Evans P and Clow A. Tribulin and stress in normal individuals.
In: Stress; Molecular Genetic and Neurobiological Advances (voII)
Eds: R.
McCarty, G. Aguilera, E. Sabban
and R. Kvetnansky. pp 877-883 (1996).
Evans P, Hucklebridge F H, Clow
A, Doyle A. Secretory Immunoglobulin A as a convienient biomarker
in health survey work. In: Health Psychology and Quality of Life
Research. Ed: Rodriques-Marin. Vol II pp541-549 (1995)
Glover V, Clow A, Przyborowska A,
Halket J, Bhattacharya SK, Sandler M. Isatin: an anxiogenic
endocoid. In: Biological Psychiatry, Vol 11 eds G Racagni, N
Brunello, T
Fukuda. Excerpta Madica,
Amsterdam, pp 637-638 (1991).
Clow A. Consequences of chronic
neuroleptic administration to rats. In: Disorders of Motor
Function, eds P Jenner, NP Quinn. Academic Press, London, pp395-407
(1989).
Glover V, Clow A, Battacharya SK,
Oxenkkrug G, Sandler M. Monoamine oxidase in stress. In: Stress.
The Role of Catecholamines and other Neurotransmitters, ed R
Kvetnansky, R McCarty, J Axelrod. Gordon and Breach, New York,
pp133-141 (1989).
Sandler V, Armanda I, Clow A,
Glover V. Tribulin, an endogenous monoamine oxidase
inhibitor-benzodiazepine receptor ligand. In: Neuronal Receptors,
Exogenous Ligands and Biotechnical Approaches, ed ME Vartanian.
International Universities Press Inc, Madison (1989).
Glover V, Clow A, Oxenkrug G,
Sandler M. Control of MAO activity in vivo. In: Progress in
Catecholamine Research, Part B: Central Aspects, eds M Sandler, A
Dahlstrom, RH Belmaker. Alan R Liss, New York, pp365-369
(1988).
Clow A, Topham A, Saunders JB,
Murray RM, Sandler M. The role of salsolinol in alcohol intake and
withdrawal. In: Aldehyde Addicts in Alcoholism, ed MA Collins. Alan
R Liss, New York, pp101-113 (1985).
Sandler M, Glover V, Clow A,
Elsworth JD. Tribulin: an endogenous monoamine oxidase
inhibitor/benzodiazepine receptor ligand. In: Endocoids, eds H Lal,
F LaBella, J Lane. Alan R Liss, New York, pp 359-362 (1985).
Glover V, Clow A, Elsworth JD,
Armando I, Sandler M. Increased output of endogenous monoamine
oxidase inhibitor in stress: a link with the benzodiazepine system.
In: Stress. The Role of Catecholamines and other Neurotransmitters,
eds E Usdin, R Kvetnansky, J Axelrod. Gordon and Breach, New York,
pp 457-465 (1984).
Glover V, Armando I, Clow A,
Sandler M. Endogenous urinary monoamine oxidase inhibitors: the
benzodiazepine connection. In: Monoamine Oxidase and its Selective
Inhibitors, eds H Beckman and P Riederer. Karger, Basel. Mod.
Probl. Pharmacopsychiat., 19, 118-125 (1983).
Sandler M, Glover V, Clow A,
Armando I. Endogenous benzodiazepine receptor ligand--monoamine
oxidase inhibitor activity in urine. In: Pharacology of
Benzodiazepines, eds E Usdin, P Skolnick, JF Tallmann Jr, D
Greenblatt, SM Paul. MacMillan, Basingstoke, pp583-589
(1982).
Sandler M, Glover V, Armando I,
Clow A. Pictet-Spengler condensation products, stress and
alcoholism: some clinical overtones. In: Beta-Carbolines and
Tetrahydroisoquinolines, eds F Bloom, J Barchas, M Sandler, E
Usdin. Alan R Liss, New York, pp 215-226 (1982).
Clow A, Jenner PJ, Theodorou A,
Marsden CD. Changes in cerebral dopamine metabolism and receptors
during one year's neuroleptic administration and subsequent
withdrawal--relevane to brain biochemistry in schizophrenia. In:
Long-term effects of neuroleptics. Advances in Biochemical
Psychopharmacology, vol 24 (eds. F Callabem, PF Spano, G Racagni, E
Costa). Raven Press, New York (1980).
Clow A, Theodorou A, Jenner PJ,
Marsden CD. Changes in cerebral dopamine function induced by a
year's administration of trifluoperazine or thioridazine and their
subsequent withdrawal. In: Long-term effects of neuroleptics.
Advances in Biochemical Psychopharmacology, vol 24 (eds. F
Callabem, PF Spano, C Racagni, E Costa). Raven Press, New York
(1980).
Jenner PJ, Clow A, Theodorou A,
Marsden CD. A comparison of the effects of chronic (six months)
administration of trifluoperazine and thioridazine on striatal
dopamine function in rats. In: Catecholamines, Basic and Clinical
Frontiers, vol 2 (Peragmon Press). Proceedings of the IVth
International Catecholamine Symposium. 1628-1630 (1979).